News Breaks |
|
|
| January 9, 2013 |
| 12:36 EDT |  | IPXL, SIG, JNS, AGN, AMJ | High option volume; IPXL SIG JNS AGN AMJ
|
|
|
News For IPXL;SIG;JNS;AGN;AMJ From The Last 14 Days Check below for free stories on IPXL;SIG;JNS;AGN;AMJ the last two weeks. |
|
|
| May 17, 2013 |
| 08:41 EDT |  | IPXL | Impax commenced shipment of authorized generic Zomig Impax (IPXL) announced that its generics division, Global Pharmaceuticals, commenced shipment of authorized generic Zomig tablets, as part of an agreement with AstraZeneca (AZN). Zomig is indicated for the treatment of migraine headaches in adults. According to IMS Health data, U.S. sales of Zomig tablets and orally disintegrating tablets were approximately $196M in the 12 months ended April 2013. |
|
| May 15, 2013 |
| 06:06 EDT |  | JNS | Janus Capital downgraded to Underweight from Overweight at Barclays Barclays downgraded Janus two notches to Underweight from Overweight citing valuation, lack of catalysts to move shares higher, and increased caution on the traditional asset manager group. Price target lowered to $8 from $9. |
|
| May 14, 2013 |
| 10:01 EDT |  | SIG | On The Fly: Analyst Initiation Summary
Subscribe for More Information |
|
| 07:57 EDT |  | SIG | Signet Jewelers initiated with an Overweight at Stephens Target $80. |
|
| 07:18 EDT |  | AGN | BofA/Merrill to host a conference 2013 Health Care Conference is being held in Las Vegas on May 14-16. |
|
| May 13, 2013 |
| 07:49 EDT |  | IPXL | FDA decision on Opana a modest positive for Impax, says Leerink Leerink views the FDA's denial of Endo's (ENDP) Citizen Petition as a modest positive for Impax (IPXL), which it notes is the sole holder of 180 day exclusivity on generic Opana. However, Leerink says upside for Impax will be limited as Actavis (ACT), Sandoz, and Teva (TEVA) have settlements to enter the market starting in June 2013 when Impax's 180-day generic exclusivity expires. |
|
| May 10, 2013 |
| 10:00 EDT |  | AGN | On The Fly: Analyst Initiation Summary Today's noteworthy initiations include: 3D Systems (DDD) initiated with a Buy at Janney Capital... Actavis (ACT) initiated with an Outperform at BMO Capital... Allergan (AGN) initiated with an Outperform at BMO Capital... Emeritus (ESC) initiated with an Outperform at Wells Fargo... Ensign Group (ENSG) initiated with a Market Perform at Wells Fargo... Forest Labs (FRX) initiated with an Underperform at BMO Capital... J2 Global (JCOM) initiated with an Outperform at Wedbush... Mylan (MYL) initiated with an Underperform at BMO Capital... Splunk (SPLK) initiated with a Market Perform at FBR Capital... Teva (TEVA) initiated with an Outperform at BMO Capital... Workday (WDAY) initiated with an Outperform at Oppenheimer... Nuance (NUAN) initiated with an Outperform at Wedbush... Demandware (DWRE) initiated with an Outperform at Wedbush... Synchronoss (SNCR) initiated with an Outperform at Wedbush... Trius Therapeutics (TSRX) initiated with a Buy at Guggenheim... Proto Labs (PRLB) initiated with a Buy at Janney Capital... Stratasys (SSYS) initiated with a Buy at Janney Capital. |
|
| May 9, 2013 |
| 16:34 EDT |  | AGN | Allergan initiated with an Outperform at BMO Capital
Subscribe for More Information |
|
| May 8, 2013 |
| 06:09 EDT |  | AGN | Stocks with implied volatility below IV index mean; EBIX AGN
Subscribe for More Information |
|
| May 7, 2013 |
| 13:08 EDT |  | AGN | Allergan can still deliver double digit earnings growth, says Argus
Subscribe for More Information |
| |
| 05:57 EDT |  | AGN | Stocks with implied volatility below IV index mean; IBM AGN
Subscribe for More Information |
|
| May 6, 2013 |
| 06:01 EDT |  | AGN | Stocks with implied volatility below IV index mean; NFLX AGN
Subscribe for More Information |
|
|
|
|
|